Binukumar BK

ORCID: 0000-0003-0933-4691
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Alzheimer's disease research and treatments
  • Genetics and Neurodevelopmental Disorders
  • Trace Elements in Health
  • Parkinson's Disease Mechanisms and Treatments
  • Pesticide Exposure and Toxicity
  • Nerve injury and regeneration
  • Autophagy in Disease and Therapy
  • Cancer-related Molecular Pathways
  • Genomics and Rare Diseases
  • Neurological diseases and metabolism
  • Microtubule and mitosis dynamics
  • RNA regulation and disease
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Heavy Metal Exposure and Toxicity
  • Neuroscience and Neuropharmacology Research
  • Coenzyme Q10 studies and effects
  • Cancer-related cognitive impairment studies
  • Neurogenetic and Muscular Disorders Research
  • Neurogenesis and neuroplasticity mechanisms
  • Neurological disorders and treatments
  • Tryptophan and brain disorders
  • Cholinesterase and Neurodegenerative Diseases
  • Computational Drug Discovery Methods
  • MicroRNA in disease regulation
  • Pain Mechanisms and Treatments

Institute of Genomics and Integrative Biology
2017-2025

Academy of Scientific and Innovative Research
2018-2025

Council of Scientific and Industrial Research
2022-2025

National Institute of Neurological Disorders and Stroke
2014-2019

National Institutes of Health
2013-2019

Centre for Chronic Disease Control
2015

Public Health Foundation of India
2015

Post Graduate Institute of Medical Education and Research
2010-2012

With the advent of next-generation sequencing, large-scale initiatives for mining whole genomes and exomes have been employed to better understand global or population-level genetic architecture. India encompasses more than 17% world population with extensive diversity, but is under-represented in sequencing datasets. This gave us impetus perform analyze genome 1029 healthy Indian individuals under pilot phase 'IndiGen' program. We generated a compendium 55,898,122 single allelic variants...

10.1093/nar/gkaa923 article EN cc-by-nc Nucleic Acids Research 2020-10-22

Long non-coding RNAs (lncRNAs) are emerging as key regulators of endothelial cell function. Here, we investigated the role a novel vascular endothelial-associated lncRNA (VEAL2) in regulating permeability. Precise editing veal2 loci zebrafish (veal2gib005Δ8/+ ) induced cranial hemorrhage. In vitro and vivo studies revealed that competes with diacylglycerol for interaction protein kinase C beta-b (Prkcbb) regulates its activity. Using PRKCB2 bait, identified functional ortholog humans from...

10.15252/embj.2020107134 article EN cc-by-nc-nd The EMBO Journal 2021-06-28

Abstract Background In recent years, several lines of evidence have shown an increase in Parkinson's disease prevalence rural environments where pesticides are heavily used. Although, the underlying mechanism for neuronal degeneration sporadic PD remains unknown, mitochondrial dysfunction, oxidative stress and proteasomal dysfunction proposed as contributing factors. this study rats were chronically continuously exposed to pesticide, dichlorvos identify molecular nigrostaital degeneration....

10.1186/1756-6606-3-35 article EN cc-by Molecular Brain 2010-11-13

Multiple lines of evidence link the incidence diabetes to development Alzheimer's disease (AD). Patients with have a 50 75% increased risk developing AD. Cyclin dependent kinase 5 (Cdk5) is serine/threonine protein kinase,

10.3233/jad-131784 article EN Journal of Alzheimer s Disease 2014-02-14

The objective of this study was to elucidate an association between Apo- Eε4 allele and CSF biomarkers Aβ42 tau for the diagnosis Alzheimer's Disease (AD) patients. protein concentrations in were measured by using ELISA assays. levels found be decreased where as increased AD Moreover patients Apo-Eε4 carriers have shown low (328.86 ± 99.0 pg/ml) compared non-carriers (367.52 5 7.37 pg/ml), while higher (511 44.67 (503.75 41.08 pg/ml). Combination resulted sensitivity 75.38% specificity...

10.2174/156720511795256071 article EN Current Alzheimer Research 1970-01-01

Parkinson’s disease (PD) is a chronic neurodegenerative disorder characterized by the loss of dopamine neurons in substantia nigra, decreased striatal levels, and consequent extrapyramidal motor dysfunction. Recent evidence indicates that cyclin-dependent kinase 5 (Cdk5) inappropriately activated several conditions, including PD. To date, strategies to specifically inhibit Cdk5 hyperactivity have not been successful without affecting normal activity. Previously we reported TFP5 peptide has...

10.1091/mbc.e15-06-0415 article EN cc-by-nc-sa Molecular Biology of the Cell 2015-09-24

It has been reported that cyclin-dependent kinase 5 (cdk5), a critical neuronal kinase, is hyperactivated in Alzheimer’s disease (AD) and may be, part, responsible for the hallmark pathology of amyloid plaques neurofibrillary tangles (NFTs). proposed by several laboratories hyperactive cdk5 results from overexpression p25 (a truncated fragment p35, normal regulator), which, when complexed to cdk5, induces hyperactivity, hyperphosphorylated tau/NFTs, amyloid-β plaques, death. previously shown...

10.3233/jad-160916 article EN Journal of Alzheimer s Disease 2017-01-12

Wilson disease (WD) is one of the most prevalent genetic diseases with an estimated global carrier frequency 1 in 90 and a prevalence 30,000. The owes its genesis to Kinnier who described disease, caused by accumulation Copper (Cu) various organs including liver, central nervous system, cornea, kidney, joints cardiac muscle which contribute characteristic clinical features WD. A number studies have reported variants ATP7B gene from diverse ethnic geographical origins. recent advent...

10.1038/s41598-020-66099-2 article EN cc-by Scientific Reports 2020-06-03

Background Advances in Next Generation Sequencing have made rapid variant discovery and detection widely accessible. To facilitate a better understanding of the nature these variants, American College Medical Genetics Genomics Association Molecular Pathologists (ACMG-AMP) issued set guidelines for classification. However, given vast number variants associated with any disorder, it is impossible to manually apply all known variants. Machine learning methodologies offer way classify large...

10.1371/journal.pone.0303787 article EN cc-by PLoS ONE 2024-05-17

Abstract Background Genomic variations associated with dystonia in Asian Indians remain largely unknown. Objectives To identify genomic alterations the Indian population using next generation sequencing approaches. Methods From September 2018 to December 2023, we enrolled 745 individuals including probands and family members, Movement Disorder Registry Biobank. Clinical demographic data were captured on a REDCap platform. We performed whole exome (WES) DNA specimens obtained from 267...

10.1002/mdc3.14325 article EN Movement Disorders Clinical Practice 2025-01-03

Type 2 diabetes (T2D) is a metabolic disorder commonly linked with cognitive decline, increasing patients' susceptibility to dementia. Alzheimer's disease (AD) has strong connection hyperglycemia and insulin dysregulation. Interestingly, certain anti-diabetic drugs have shown potential in reducing T2D-induced impairment. Previous studies, including ours, highlighted the dysregulation of cyclin-dependent kinase 5 (Cdk5) activity both T2D AD, which may contribute pathological changes these...

10.1016/j.isci.2025.112200 article EN cc-by iScience 2025-03-11

10.1016/j.bbadis.2023.166986 article EN publisher-specific-oa Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2023-12-11

Abstract Background One of the pathological hallmarks Alzheimer's disease (AD) is deposition ~4 kDa amyloid β protein (Aβ) within lesions known as senile plaques. Aβ also deposited in walls cerebral blood vessels many cases AD. A substantial proportion that accumulates AD brain Amyloid, which highly insoluble, proteinaceous material with a β-pleated-sheet conformation and extracellularly form 5-10 nm wide straight fibrils. As γ-secretase catalyzes final cleavage releases Aβ42 or 40 from...

10.1186/1423-0127-19-2 article EN cc-by Journal of Biomedical Science 2012-01-03

Abstract Cyclin-dependent kinase 5 (Cdk5) is a key neuronal that upregulated during inflammation, and can subsequently modulate sensitivity to nociceptive stimuli. We conducted an in silico screen for Cdk5 phosphorylation sites within proteins whose expression was enriched nociceptors identified the chemo-responsive ion channel Transient Receptor Potential Ankyrin 1 (TRPA1) as possible substrate. Immunoprecipitated full length TRPA1 shown be phosphorylated by this interaction blocked TFP5,...

10.1038/s41598-018-19532-6 article EN cc-by Scientific Reports 2018-01-15
Coming Soon ...